← Evidence map

ArticlePulmonary therapy2025

Real-World Effectiveness of Bebtelovimab Versus Nirmatrelvir/Ritonavir in Outpatients with COVID-19.

Christopher G Rowan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

1 paper cites it

2025
this paperpooled itcites it
Full record →Abstract, authors, funding and every citing paper · PMID 39722116